From the AGA Journals

Poor performance seen after optical biopsy training

Publish date: January 3, 2013

 

FROM GASTROENTEROLOGY

This study was supported by Stanford University. One author reported receiving research support from and serving on the speakers bureau for Olympus Corp.

Pages

Recommended Reading

Long-Term Follow-Up Warranted After Gastric MALT Lymphoma Remission
MDedge Hematology and Oncology
FDA Approves Regorafenib for Metastatic Colorectal Cancer
MDedge Hematology and Oncology
Gefitinib Offers Palliative Care in Advanced Esophageal Cancer
MDedge Hematology and Oncology
Management of Zollinger-Ellison May Depend on Presence of Tumors
MDedge Hematology and Oncology
Less Liver Cancer in HCV Patients Given Antiviral Therapy
MDedge Hematology and Oncology
Evidence Mounts for Continuing Bevacizumab After Colorectal Cancer Progresses
MDedge Hematology and Oncology
Antivirals Linked to Lower Risk of Liver Cancer Return
MDedge Hematology and Oncology
Earlier End-of-Life Talks Deter Aggressive Care of Terminal Cancer Patients
MDedge Hematology and Oncology
Brivanib Can't Match Sorafenib for Advanced Liver Cancer
MDedge Hematology and Oncology
Tivantinib Shows Modest Benefit in Relapsed Liver Cancer
MDedge Hematology and Oncology